nodes	percent_of_prediction	percent_of_DWPC	metapath
Everolimus—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0961	0.248	CbGbCtD
Everolimus—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0728	0.188	CbGbCtD
Everolimus—CYP3A4—Betamethasone—ankylosing spondylitis	0.0625	0.161	CbGbCtD
Everolimus—CYP3A4—Prednisolone—ankylosing spondylitis	0.0617	0.159	CbGbCtD
Everolimus—CYP3A4—Prednisone—ankylosing spondylitis	0.0582	0.15	CbGbCtD
Everolimus—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0363	0.0938	CbGbCtD
Everolimus—Stomatitis—Methotrexate—ankylosing spondylitis	0.00049	0.000799	CcSEcCtD
Everolimus—Angiopathy—Prednisone—ankylosing spondylitis	0.000489	0.000799	CcSEcCtD
Everolimus—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000488	0.000797	CcSEcCtD
Everolimus—Immune system disorder—Prednisone—ankylosing spondylitis	0.000487	0.000796	CcSEcCtD
Everolimus—Malaise—Dexamethasone—ankylosing spondylitis	0.000486	0.000794	CcSEcCtD
Everolimus—Malaise—Betamethasone—ankylosing spondylitis	0.000486	0.000794	CcSEcCtD
Everolimus—Oedema—Triamcinolone—ankylosing spondylitis	0.000485	0.000792	CcSEcCtD
Everolimus—Syncope—Betamethasone—ankylosing spondylitis	0.000484	0.00079	CcSEcCtD
Everolimus—Syncope—Dexamethasone—ankylosing spondylitis	0.000484	0.00079	CcSEcCtD
Everolimus—Infection—Triamcinolone—ankylosing spondylitis	0.000482	0.000787	CcSEcCtD
Everolimus—Infection—Methylprednisolone—ankylosing spondylitis	0.000481	0.000785	CcSEcCtD
Everolimus—Haematuria—Methotrexate—ankylosing spondylitis	0.000479	0.000782	CcSEcCtD
Everolimus—Shock—Triamcinolone—ankylosing spondylitis	0.000477	0.000779	CcSEcCtD
Everolimus—Insomnia—Prednisolone—ankylosing spondylitis	0.000477	0.000779	CcSEcCtD
Everolimus—Alopecia—Prednisone—ankylosing spondylitis	0.000477	0.000779	CcSEcCtD
Everolimus—Shock—Methylprednisolone—ankylosing spondylitis	0.000476	0.000778	CcSEcCtD
Everolimus—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000475	0.000776	CcSEcCtD
Everolimus—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000475	0.000775	CcSEcCtD
Everolimus—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000474	0.000774	CcSEcCtD
Everolimus—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000474	0.000774	CcSEcCtD
Everolimus—Epistaxis—Methotrexate—ankylosing spondylitis	0.000474	0.000774	CcSEcCtD
Everolimus—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000474	0.000773	CcSEcCtD
Everolimus—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000473	0.000773	CcSEcCtD
Everolimus—Mental disorder—Prednisone—ankylosing spondylitis	0.000473	0.000772	CcSEcCtD
Everolimus—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000472	0.000771	CcSEcCtD
Everolimus—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00047	0.000768	CcSEcCtD
Everolimus—Malnutrition—Prednisone—ankylosing spondylitis	0.00047	0.000767	CcSEcCtD
Everolimus—Erythema—Prednisone—ankylosing spondylitis	0.00047	0.000767	CcSEcCtD
Everolimus—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000469	0.000766	CcSEcCtD
Everolimus—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000468	0.000764	CcSEcCtD
Everolimus—Convulsion—Betamethasone—ankylosing spondylitis	0.000467	0.000763	CcSEcCtD
Everolimus—Convulsion—Dexamethasone—ankylosing spondylitis	0.000467	0.000763	CcSEcCtD
Everolimus—Hypertension—Dexamethasone—ankylosing spondylitis	0.000466	0.00076	CcSEcCtD
Everolimus—Hypertension—Betamethasone—ankylosing spondylitis	0.000466	0.00076	CcSEcCtD
Everolimus—Myalgia—Dexamethasone—ankylosing spondylitis	0.000459	0.00075	CcSEcCtD
Everolimus—Myalgia—Betamethasone—ankylosing spondylitis	0.000459	0.00075	CcSEcCtD
Everolimus—Anxiety—Betamethasone—ankylosing spondylitis	0.000457	0.000747	CcSEcCtD
Everolimus—Anxiety—Dexamethasone—ankylosing spondylitis	0.000457	0.000747	CcSEcCtD
Everolimus—Discomfort—Dexamethasone—ankylosing spondylitis	0.000454	0.000741	CcSEcCtD
Everolimus—Discomfort—Betamethasone—ankylosing spondylitis	0.000454	0.000741	CcSEcCtD
Everolimus—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000453	0.00074	CcSEcCtD
Everolimus—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000452	0.000739	CcSEcCtD
Everolimus—Pain—Prednisolone—ankylosing spondylitis	0.000451	0.000737	CcSEcCtD
Everolimus—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000451	0.000736	CcSEcCtD
Everolimus—Hepatitis—Methotrexate—ankylosing spondylitis	0.000451	0.000736	CcSEcCtD
Everolimus—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000447	0.000731	CcSEcCtD
Everolimus—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000445	0.000727	CcSEcCtD
Everolimus—Vision blurred—Prednisone—ankylosing spondylitis	0.000443	0.000723	CcSEcCtD
Everolimus—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000442	0.000722	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000442	0.000722	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000441	0.00072	CcSEcCtD
Everolimus—Oedema—Dexamethasone—ankylosing spondylitis	0.00044	0.000719	CcSEcCtD
Everolimus—Oedema—Betamethasone—ankylosing spondylitis	0.00044	0.000719	CcSEcCtD
Everolimus—Insomnia—Triamcinolone—ankylosing spondylitis	0.000439	0.000716	CcSEcCtD
Everolimus—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000438	0.000715	CcSEcCtD
Everolimus—Infection—Dexamethasone—ankylosing spondylitis	0.000437	0.000714	CcSEcCtD
Everolimus—Infection—Betamethasone—ankylosing spondylitis	0.000437	0.000714	CcSEcCtD
Everolimus—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000436	0.000712	CcSEcCtD
Everolimus—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000436	0.000711	CcSEcCtD
Everolimus—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000435	0.00071	CcSEcCtD
Everolimus—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000435	0.00071	CcSEcCtD
Everolimus—Anaemia—Prednisone—ankylosing spondylitis	0.000434	0.000709	CcSEcCtD
Everolimus—Shock—Dexamethasone—ankylosing spondylitis	0.000433	0.000707	CcSEcCtD
Everolimus—Shock—Betamethasone—ankylosing spondylitis	0.000433	0.000707	CcSEcCtD
Everolimus—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000432	0.000706	CcSEcCtD
Everolimus—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000432	0.000705	CcSEcCtD
Everolimus—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000432	0.000705	CcSEcCtD
Everolimus—Agitation—Prednisone—ankylosing spondylitis	0.000432	0.000705	CcSEcCtD
Everolimus—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000431	0.000704	CcSEcCtD
Everolimus—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000431	0.000704	CcSEcCtD
Everolimus—Tachycardia—Betamethasone—ankylosing spondylitis	0.00043	0.000701	CcSEcCtD
Everolimus—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00043	0.000701	CcSEcCtD
Everolimus—Angioedema—Prednisone—ankylosing spondylitis	0.000429	0.000701	CcSEcCtD
Everolimus—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000427	0.000697	CcSEcCtD
Everolimus—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000426	0.000696	CcSEcCtD
Everolimus—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000425	0.000695	CcSEcCtD
Everolimus—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000425	0.000695	CcSEcCtD
Everolimus—Malaise—Prednisone—ankylosing spondylitis	0.000423	0.000692	CcSEcCtD
Everolimus—Eye disorder—Methotrexate—ankylosing spondylitis	0.000421	0.000688	CcSEcCtD
Everolimus—Syncope—Prednisone—ankylosing spondylitis	0.000421	0.000688	CcSEcCtD
Everolimus—Anorexia—Betamethasone—ankylosing spondylitis	0.000419	0.000685	CcSEcCtD
Everolimus—Anorexia—Dexamethasone—ankylosing spondylitis	0.000419	0.000685	CcSEcCtD
Everolimus—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000418	0.000683	CcSEcCtD
Everolimus—Fatigue—Triamcinolone—ankylosing spondylitis	0.000418	0.000683	CcSEcCtD
Everolimus—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000417	0.000681	CcSEcCtD
Everolimus—Pain—Triamcinolone—ankylosing spondylitis	0.000415	0.000677	CcSEcCtD
Everolimus—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000413	0.000674	CcSEcCtD
Everolimus—Hypotension—Betamethasone—ankylosing spondylitis	0.000411	0.000672	CcSEcCtD
Everolimus—Hypotension—Dexamethasone—ankylosing spondylitis	0.000411	0.000672	CcSEcCtD
Everolimus—Angiopathy—Methotrexate—ankylosing spondylitis	0.000409	0.000668	CcSEcCtD
Everolimus—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000407	0.000665	CcSEcCtD
Everolimus—Convulsion—Prednisone—ankylosing spondylitis	0.000407	0.000665	CcSEcCtD
Everolimus—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000406	0.000664	CcSEcCtD
Everolimus—Hypertension—Prednisone—ankylosing spondylitis	0.000405	0.000662	CcSEcCtD
Everolimus—Chills—Methotrexate—ankylosing spondylitis	0.000405	0.000661	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000401	0.000655	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000401	0.000655	CcSEcCtD
Everolimus—Arthralgia—Prednisone—ankylosing spondylitis	0.0004	0.000653	CcSEcCtD
Everolimus—Myalgia—Prednisone—ankylosing spondylitis	0.0004	0.000653	CcSEcCtD
Everolimus—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.0004	0.000653	CcSEcCtD
Everolimus—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000399	0.000651	CcSEcCtD
Everolimus—Anxiety—Prednisone—ankylosing spondylitis	0.000398	0.000651	CcSEcCtD
Everolimus—Alopecia—Methotrexate—ankylosing spondylitis	0.000398	0.000651	CcSEcCtD
Everolimus—Insomnia—Betamethasone—ankylosing spondylitis	0.000398	0.00065	CcSEcCtD
Everolimus—Insomnia—Dexamethasone—ankylosing spondylitis	0.000398	0.00065	CcSEcCtD
Everolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000397	0.000648	CcSEcCtD
Everolimus—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000396	0.000646	CcSEcCtD
Everolimus—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000395	0.000645	CcSEcCtD
Everolimus—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000395	0.000645	CcSEcCtD
Everolimus—Discomfort—Prednisone—ankylosing spondylitis	0.000395	0.000645	CcSEcCtD
Everolimus—Mental disorder—Methotrexate—ankylosing spondylitis	0.000395	0.000645	CcSEcCtD
Everolimus—Malnutrition—Methotrexate—ankylosing spondylitis	0.000392	0.000641	CcSEcCtD
Everolimus—Erythema—Methotrexate—ankylosing spondylitis	0.000392	0.000641	CcSEcCtD
Everolimus—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000389	0.000635	CcSEcCtD
Everolimus—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000387	0.000633	CcSEcCtD
Everolimus—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000387	0.000633	CcSEcCtD
Everolimus—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000384	0.000628	CcSEcCtD
Everolimus—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000383	0.000626	CcSEcCtD
Everolimus—Oedema—Prednisone—ankylosing spondylitis	0.000383	0.000626	CcSEcCtD
Everolimus—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000383	0.000625	CcSEcCtD
Everolimus—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000383	0.000625	CcSEcCtD
Everolimus—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000383	0.000625	CcSEcCtD
Everolimus—Infection—Prednisone—ankylosing spondylitis	0.000381	0.000622	CcSEcCtD
Everolimus—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00038	0.000621	CcSEcCtD
Everolimus—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00038	0.000621	CcSEcCtD
Everolimus—Back pain—Methotrexate—ankylosing spondylitis	0.00038	0.00062	CcSEcCtD
Everolimus—Fatigue—Dexamethasone—ankylosing spondylitis	0.000379	0.00062	CcSEcCtD
Everolimus—Fatigue—Betamethasone—ankylosing spondylitis	0.000379	0.00062	CcSEcCtD
Everolimus—Shock—Prednisone—ankylosing spondylitis	0.000377	0.000616	CcSEcCtD
Everolimus—Pain—Betamethasone—ankylosing spondylitis	0.000376	0.000615	CcSEcCtD
Everolimus—Pain—Dexamethasone—ankylosing spondylitis	0.000376	0.000615	CcSEcCtD
Everolimus—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000376	0.000614	CcSEcCtD
Everolimus—Tachycardia—Prednisone—ankylosing spondylitis	0.000374	0.000611	CcSEcCtD
Everolimus—Skin disorder—Prednisone—ankylosing spondylitis	0.000372	0.000608	CcSEcCtD
Everolimus—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000371	0.000605	CcSEcCtD
Everolimus—Vision blurred—Methotrexate—ankylosing spondylitis	0.00037	0.000604	CcSEcCtD
Everolimus—Anorexia—Prednisone—ankylosing spondylitis	0.000365	0.000597	CcSEcCtD
Everolimus—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000364	0.000595	CcSEcCtD
Everolimus—Anaemia—Methotrexate—ankylosing spondylitis	0.000363	0.000592	CcSEcCtD
Everolimus—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000363	0.000592	CcSEcCtD
Everolimus—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000363	0.000592	CcSEcCtD
Everolimus—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00036	0.000588	CcSEcCtD
Everolimus—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00036	0.000588	CcSEcCtD
Everolimus—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000357	0.000584	CcSEcCtD
Everolimus—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000357	0.000582	CcSEcCtD
Everolimus—Malaise—Methotrexate—ankylosing spondylitis	0.000354	0.000578	CcSEcCtD
Everolimus—Leukopenia—Methotrexate—ankylosing spondylitis	0.000351	0.000574	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000349	0.00057	CcSEcCtD
Everolimus—Dizziness—Prednisolone—ankylosing spondylitis	0.000349	0.00057	CcSEcCtD
Everolimus—Asthenia—Triamcinolone—ankylosing spondylitis	0.000348	0.000568	CcSEcCtD
Everolimus—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000348	0.000568	CcSEcCtD
Everolimus—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000348	0.000568	CcSEcCtD
Everolimus—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000348	0.000568	CcSEcCtD
Everolimus—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000348	0.000568	CcSEcCtD
Everolimus—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000347	0.000567	CcSEcCtD
Everolimus—Insomnia—Prednisone—ankylosing spondylitis	0.000347	0.000566	CcSEcCtD
Everolimus—Paraesthesia—Prednisone—ankylosing spondylitis	0.000344	0.000562	CcSEcCtD
Everolimus—Pruritus—Triamcinolone—ankylosing spondylitis	0.000343	0.00056	CcSEcCtD
Everolimus—Cough—Methotrexate—ankylosing spondylitis	0.000342	0.000559	CcSEcCtD
Everolimus—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000342	0.000559	CcSEcCtD
Everolimus—Convulsion—Methotrexate—ankylosing spondylitis	0.00034	0.000555	CcSEcCtD
Everolimus—Dyspepsia—Prednisone—ankylosing spondylitis	0.000337	0.000551	CcSEcCtD
Everolimus—Chest pain—Methotrexate—ankylosing spondylitis	0.000334	0.000546	CcSEcCtD
Everolimus—Arthralgia—Methotrexate—ankylosing spondylitis	0.000334	0.000546	CcSEcCtD
Everolimus—Myalgia—Methotrexate—ankylosing spondylitis	0.000334	0.000546	CcSEcCtD
Everolimus—Decreased appetite—Prednisone—ankylosing spondylitis	0.000333	0.000544	CcSEcCtD
Everolimus—Rash—Prednisolone—ankylosing spondylitis	0.000333	0.000543	CcSEcCtD
Everolimus—Dermatitis—Prednisolone—ankylosing spondylitis	0.000332	0.000543	CcSEcCtD
Everolimus—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000332	0.000542	CcSEcCtD
Everolimus—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000331	0.000541	CcSEcCtD
Everolimus—Fatigue—Prednisone—ankylosing spondylitis	0.00033	0.00054	CcSEcCtD
Everolimus—Headache—Prednisolone—ankylosing spondylitis	0.00033	0.00054	CcSEcCtD
Everolimus—Discomfort—Methotrexate—ankylosing spondylitis	0.00033	0.000539	CcSEcCtD
Everolimus—Constipation—Prednisone—ankylosing spondylitis	0.000328	0.000535	CcSEcCtD
Everolimus—Dizziness—Triamcinolone—ankylosing spondylitis	0.000321	0.000524	CcSEcCtD
Everolimus—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00032	0.000523	CcSEcCtD
Everolimus—Infection—Methotrexate—ankylosing spondylitis	0.000318	0.00052	CcSEcCtD
Everolimus—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000316	0.000516	CcSEcCtD
Everolimus—Asthenia—Betamethasone—ankylosing spondylitis	0.000316	0.000516	CcSEcCtD
Everolimus—Asthenia—Dexamethasone—ankylosing spondylitis	0.000316	0.000516	CcSEcCtD
Everolimus—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000314	0.000513	CcSEcCtD
Everolimus—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000314	0.000512	CcSEcCtD
Everolimus—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000313	0.000512	CcSEcCtD
Everolimus—Nausea—Prednisolone—ankylosing spondylitis	0.000313	0.000512	CcSEcCtD
Everolimus—Pruritus—Betamethasone—ankylosing spondylitis	0.000311	0.000509	CcSEcCtD
Everolimus—Pruritus—Dexamethasone—ankylosing spondylitis	0.000311	0.000509	CcSEcCtD
Everolimus—Skin disorder—Methotrexate—ankylosing spondylitis	0.000311	0.000508	CcSEcCtD
Everolimus—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00031	0.000506	CcSEcCtD
Everolimus—Vomiting—Triamcinolone—ankylosing spondylitis	0.000308	0.000504	CcSEcCtD
Everolimus—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000308	0.000503	CcSEcCtD
Everolimus—Rash—Triamcinolone—ankylosing spondylitis	0.000306	0.000499	CcSEcCtD
Everolimus—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000306	0.000499	CcSEcCtD
Everolimus—Anorexia—Methotrexate—ankylosing spondylitis	0.000305	0.000499	CcSEcCtD
Everolimus—Rash—Methylprednisolone—ankylosing spondylitis	0.000305	0.000498	CcSEcCtD
Everolimus—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000305	0.000498	CcSEcCtD
Everolimus—Headache—Triamcinolone—ankylosing spondylitis	0.000304	0.000496	CcSEcCtD
Everolimus—Headache—Methylprednisolone—ankylosing spondylitis	0.000303	0.000495	CcSEcCtD
Everolimus—Abdominal pain—Prednisone—ankylosing spondylitis	0.000303	0.000495	CcSEcCtD
Everolimus—Body temperature increased—Prednisone—ankylosing spondylitis	0.000303	0.000495	CcSEcCtD
Everolimus—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000301	0.000492	CcSEcCtD
Everolimus—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000301	0.000492	CcSEcCtD
Everolimus—Hypotension—Methotrexate—ankylosing spondylitis	0.000299	0.000489	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000292	0.000477	CcSEcCtD
Everolimus—Dizziness—Dexamethasone—ankylosing spondylitis	0.000291	0.000475	CcSEcCtD
Everolimus—Dizziness—Betamethasone—ankylosing spondylitis	0.000291	0.000475	CcSEcCtD
Everolimus—Insomnia—Methotrexate—ankylosing spondylitis	0.00029	0.000473	CcSEcCtD
Everolimus—Nausea—Triamcinolone—ankylosing spondylitis	0.000288	0.000471	CcSEcCtD
Everolimus—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000288	0.00047	CcSEcCtD
Everolimus—Nausea—Methylprednisolone—ankylosing spondylitis	0.000287	0.000469	CcSEcCtD
Everolimus—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000286	0.000466	CcSEcCtD
Everolimus—Somnolence—Methotrexate—ankylosing spondylitis	0.000285	0.000465	CcSEcCtD
Everolimus—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000282	0.000461	CcSEcCtD
Everolimus—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000282	0.00046	CcSEcCtD
Everolimus—Vomiting—Betamethasone—ankylosing spondylitis	0.00028	0.000457	CcSEcCtD
Everolimus—Vomiting—Dexamethasone—ankylosing spondylitis	0.00028	0.000457	CcSEcCtD
Everolimus—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000278	0.000455	CcSEcCtD
Everolimus—Rash—Dexamethasone—ankylosing spondylitis	0.000277	0.000453	CcSEcCtD
Everolimus—Rash—Betamethasone—ankylosing spondylitis	0.000277	0.000453	CcSEcCtD
Everolimus—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000277	0.000453	CcSEcCtD
Everolimus—Dermatitis—Betamethasone—ankylosing spondylitis	0.000277	0.000453	CcSEcCtD
Everolimus—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000277	0.000452	CcSEcCtD
Everolimus—Fatigue—Methotrexate—ankylosing spondylitis	0.000276	0.000451	CcSEcCtD
Everolimus—Headache—Dexamethasone—ankylosing spondylitis	0.000276	0.00045	CcSEcCtD
Everolimus—Headache—Betamethasone—ankylosing spondylitis	0.000276	0.00045	CcSEcCtD
Everolimus—Asthenia—Prednisone—ankylosing spondylitis	0.000275	0.000449	CcSEcCtD
Everolimus—Pain—Methotrexate—ankylosing spondylitis	0.000274	0.000447	CcSEcCtD
Everolimus—Pruritus—Prednisone—ankylosing spondylitis	0.000271	0.000443	CcSEcCtD
Everolimus—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000264	0.000431	CcSEcCtD
Everolimus—Diarrhoea—Prednisone—ankylosing spondylitis	0.000262	0.000428	CcSEcCtD
Everolimus—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000262	0.000428	CcSEcCtD
Everolimus—Nausea—Betamethasone—ankylosing spondylitis	0.000261	0.000427	CcSEcCtD
Everolimus—Nausea—Dexamethasone—ankylosing spondylitis	0.000261	0.000427	CcSEcCtD
Everolimus—Dizziness—Prednisone—ankylosing spondylitis	0.000253	0.000414	CcSEcCtD
Everolimus—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000253	0.000414	CcSEcCtD
Everolimus—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000253	0.000414	CcSEcCtD
Everolimus—Vomiting—Prednisone—ankylosing spondylitis	0.000244	0.000398	CcSEcCtD
Everolimus—Rash—Prednisone—ankylosing spondylitis	0.000242	0.000395	CcSEcCtD
Everolimus—Dermatitis—Prednisone—ankylosing spondylitis	0.000241	0.000394	CcSEcCtD
Everolimus—Headache—Prednisone—ankylosing spondylitis	0.00024	0.000392	CcSEcCtD
Everolimus—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000236	0.000385	CcSEcCtD
Everolimus—Asthenia—Methotrexate—ankylosing spondylitis	0.00023	0.000375	CcSEcCtD
Everolimus—Nausea—Prednisone—ankylosing spondylitis	0.000228	0.000372	CcSEcCtD
Everolimus—Pruritus—Methotrexate—ankylosing spondylitis	0.000227	0.00037	CcSEcCtD
Everolimus—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000219	0.000358	CcSEcCtD
Everolimus—Dizziness—Methotrexate—ankylosing spondylitis	0.000212	0.000346	CcSEcCtD
Everolimus—Vomiting—Methotrexate—ankylosing spondylitis	0.000204	0.000333	CcSEcCtD
Everolimus—Rash—Methotrexate—ankylosing spondylitis	0.000202	0.00033	CcSEcCtD
Everolimus—Dermatitis—Methotrexate—ankylosing spondylitis	0.000202	0.00033	CcSEcCtD
Everolimus—Headache—Methotrexate—ankylosing spondylitis	0.000201	0.000328	CcSEcCtD
Everolimus—Nausea—Methotrexate—ankylosing spondylitis	0.00019	0.000311	CcSEcCtD
